Chong Kun Dang Pharmaceutical: Hypertension trials

The registry lists 46 Hypertension studies with Chong Kun Dang Pharmaceutical as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 23Phase 2 4Phase 3 12Phase 4 6No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy VolunteersNot yet recruitingNCT07748702Phase 1
• Efficacy and Safety of Telmisartan Compared With LosartanRecruitingNCT06431477Phase 4
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy AdultsCompletedNCT06281132Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 MonotherapyCompletedNCT06121518Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination TherapyCompletedNCT05931224Phase 3
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy AdultsCompletedNCT05921435Phase 1
• A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mgCompletedNCT05881707Phase 1
• A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828CompletedNCT05834595Phase 1
• Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy SubjectsCompletedNCT05571813Phase 1
• Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy SubjectsCompletedNCT05540912Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination TherapyStatus unknownNCT05526703Phase 3
• A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedNCT04521023Phase 4
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351Status unknownNCT04448223Phase 2
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-386CompletedNCT04312698Phase 3
• A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012Status unknownNCT04035538Phase 1
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351Status unknownNCT03762369Phase 3
• Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy VolunteersStatus unknownNCT03748212Phase 1
• A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy SubjectsStatus unknownNCT03726866Phase 1
• Pharmacokinetics and Safety Profile of CKD-333CompletedNCT03659149Phase 1
• A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male SubjectsCompletedNCT03609606Phase 1
• Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once DailyStatus unknownNCT03067415Phase 2
• Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart FailureStatus unknownNCT03063697
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - BCompletedNCT02811731Phase 1
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - ACompletedNCT02801526Phase 1
• Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedNCT02651870Phase 3
• CKD-330 Phase 3 Trial in Amlodipine Non-responderCompletedNCT02586311Phase 3
• Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsCompletedNCT02548286Phase 1
• Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately ControlledStatus unknownNCT02526875Phase 4
• CKD-828 (80/5mg) Pharmacokinetic StudyCompletedNCT02358824Phase 1
• CKD-828 (80/5mg) Pharmacokinetic StudyCompletedNCT02250833Phase 1
• The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan MonotherapyCompletedNCT02231788Phase 4
• A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionStatus unknownNCT02206165Phase 2
• Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)CompletedNCT02186496Phase 1
• CKD-330 Drug-Drug Interaction Study (Candesartan)CompletedNCT02064621Phase 1
• CKD-330 Drug-Drug Interaction Study (Amlodipine)CompletedNCT02064556Phase 1
• Efficacy and Safety of TELMINUVO to Stage 2 HypertensionStatus unknownNCT01983735Phase 3
• The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)TerminatedNCT01766505Phase 4
• Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential HypertensionCompletedNCT01756430Phase 3
• To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedNCT01682564Phase 4
• Efficacy and Safety of CKD-828 to Stage 2 HypertensionCompletedNCT01634295Phase 3
• CKD-828 S-Amlodipine Non-Responder TrialCompletedNCT01501253Phase 3
• CKD-828 Telmisartan Non-Responder TrialCompletedNCT01426100Phase 3
• CKD-828(80/2.5mg) Pharmacokinetic Study_2ndCompletedNCT01352689Phase 1
• CKD-828 (40/5mg) Pharmacokinetic StudyCompletedNCT01340131Phase 1
• CKD-828(80/2.5mg) Pharmacokinetic StudyCompletedNCT01246193Phase 1
• CKD-828 Primary Hypertension Trial(Dose-selection)CompletedNCT01128322Phase 2